$2.5M Department of Defense grant funds triple-negative breast cancer therapies
July 17, 2026
July 17, 2026
ITHACA, New York, July 17 -- Cornell University posted the following news:
* * *
$2.5M Department of Defense grant funds triple-negative breast cancer therapies
*
Weill Cornell Medicine has received a three-year, $2.5 million grant from the Department of Defense (DoD) to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.
The highly competit . . .
* * *
$2.5M Department of Defense grant funds triple-negative breast cancer therapies
*
Weill Cornell Medicine has received a three-year, $2.5 million grant from the Department of Defense (DoD) to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.
The highly competit . . .